{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:11:18Z","timestamp":1788811878829,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,7]]},"DOI":"10.7759\/cureus.115909","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:24:21Z","timestamp":1788809061000},"source":"Crossref","is-referenced-by-count":0,"title":["Prenatal Use of Sirolimus in Fetal Therapy: Current Evidence, Clinical Applications, and Future Directions"],"prefix":"10.7759","author":[{"given":"Zbigniew","family":"Ruszczak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Strzelecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Respondek-Liberska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton RA","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017, 168:960-76. 10.1016\/j.cell.2017.02.004","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante M","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012, 149:274-93. 10.1016\/j.cell.2012.03.017","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup H","year":"2013","unstructured":"Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013, 49:243-54. 10.1016\/j.pediatrneurol.2013.08.001","journal-title":"Pediatr Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske EP","year":"2016","unstructured":"Henske EP, J\u00f3\u017awiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016, 2:16035. 10.1038\/nrdp.2016.35","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams DM","year":"2016","unstructured":"Adams DM, Trenor CC, Hammill AM, et al.. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016, 137:e20153257. 10.1542\/peds.2015-3257","journal-title":"Pediatrics"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2019.06.217","article-title":"Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review","volume":"71","author":"Freixo C","year":"2020","unstructured":"Freixo C, Ferreira V, Martins J, et al.. Efficacy and safety of sirolimus in the treatment of vascular anomalies: a systematic review. J Vasc Surg. 2020, 71:318-27. 10.1016\/j.jvs.2019.06.217","journal-title":"J Vasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1593383","article-title":"Sirolimus in the treatment of vascular anomalies","volume":"27","author":"Triana P","year":"2017","unstructured":"Triana P, Dore M, Cerezo VN, et al.. Sirolimus in the treatment of vascular anomalies. Eur J Pediatr Surg. 2017, 27:86-90. 10.1055\/s-0036-1593383","journal-title":"Eur J Pediatr Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0934-z","article-title":"Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study","volume":"13","author":"Hammer J","year":"2018","unstructured":"Hammer J, Seront E, Duez S, et al.. Sirolimus is efficacious in treatment for extensive and\/or complex slow-flow vascular malformations: a monocentric prospective phase II study. Orphanet J Rare Dis. 2018, 13:191. 10.1186\/s13023-018-0934-z","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1800352","article-title":"Maternal sirolimus therapy for fetal cardiac rhabdomyomas","volume":"378","author":"Barnes BT","year":"2018","unstructured":"Barnes BT, Procaccini D, Crino J, et al.. Maternal sirolimus therapy for fetal cardiac rhabdomyomas. N Engl J Med. 2018, 378:1844-5. 10.1056\/NEJMc1800352","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2019.62.4.280","article-title":"Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis","volume":"62","author":"Park H","year":"2019","unstructured":"Park H, Chang CS, Choi SJ, Oh SY, Roh CR. Sirolimus therapy for fetal cardiac rhabdomyoma in a pregnant woman with tuberous sclerosis. Obstet Gynecol Sci. 2019, 62:280-4. 10.5468\/ogs.2019.62.4.280","journal-title":"Obstet Gynecol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/uog.20196","article-title":"In-utero treatment of large symptomatic rhabdomyoma with sirolimus","volume":"53","author":"Vachon-Marceau C","year":"2019","unstructured":"Vachon-Marceau C, Guerra V, Jaeggi E, Chau V, Ryan G, Van Mieghem T. In-utero treatment of large symptomatic rhabdomyoma with sirolimus. Ultrasound Obstet Gynecol. 2019, 53:420-1. 10.1002\/uog.20196","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pd.5613","article-title":"Fetal cardiac rhabdomyomas treated with maternal sirolimus","volume":"40","author":"Pluym ID","year":"2020","unstructured":"Pluym ID, Sklansky M, Wu JY, et al.. Fetal cardiac rhabdomyomas treated with maternal sirolimus. Prenat Diagn. 2020, 40:358-64. 10.1002\/pd.5613","journal-title":"Prenat Diagn"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/15513815.2021.1948646","article-title":"Fetal tuberous sclerosis: sirolimus for the treatment of fetal rhabdomyoma","volume":"41","author":"Dagge A","year":"2022","unstructured":"Dagge A, Silva LA, Jorge S, Nogueira E, Rebelo M, Pinto L. Fetal tuberous sclerosis: sirolimus for the treatment of fetal rhabdomyoma. Fetal Pediatr Pathol. 2022, 41:800-6. 10.1080\/15513815.2021.1948646","journal-title":"Fetal Pediatr Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2021.09.014","article-title":"Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis","volume":"125","author":"Ebrahimi-Fakhari D","year":"2021","unstructured":"Ebrahimi-Fakhari D, Stires G, Hahn E, Krueger D, Franz DN. Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis. Pediatr Neurol. 2021, 125:26-31. 10.1016\/j.pediatrneurol.2021.09.014","journal-title":"Pediatr Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/pediatric15010020","article-title":"Successful prenatal treatment of cardiac rhabdomyoma in a fetus with tuberous sclerosis","volume":"15","author":"Will JC","year":"2023","unstructured":"Will JC, Siedentopf N, Schmid O, Gruber TM, Henrich W, Hertzberg C, Weschke B. Successful prenatal treatment of cardiac rhabdomyoma in a fetus with tuberous sclerosis. Pediatr Rep. 2023, 15:245-53. 10.3390\/pediatric15010020","journal-title":"Pediatr Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1159\/000542664","article-title":"Transplacental sirolimus for reversal of fetal heart failure due to fetal cardiac rhabdomyoma: fetal and maternal considerations","volume":"52","author":"Gon\u00e7alves MB","year":"2025","unstructured":"Gon\u00e7alves MB, Carvalho MA, Favaro GA, et al.. Transplacental sirolimus for reversal of fetal heart failure due to fetal cardiac rhabdomyoma: fetal and maternal considerations. Fetal Diagn Ther. 2025, 52:420-8. 10.1159\/000542664","journal-title":"Fetal Diagn Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03780-7","article-title":"Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas-a case report","volume":"20","author":"Uno K","year":"2025","unstructured":"Uno K, Nomura Y, Kawaguchi M, Ebina A, Imanishi R, Kawai S, Hayakawa H. Transplacental sirolimus: a new treatment strategy for life-threatening fetal cardiac rhabdomyomas-a case report. Orphanet J Rare Dis. 2025, 20:291. 10.1186\/s13023-025-03780-7","journal-title":"Orphanet J Rare Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1711774","article-title":"Fetal cardiac rhabdomyomas susceptible to prenatal treatment with mTOR inhibitors: literature review and proposal of a prenatal management algorithm","volume":"12","author":"Martinez-Garcia A","year":"2025","unstructured":"Martinez-Garcia A, Tirado-Aguilar OA, Acevedo-Gallegos S, et al.. Fetal cardiac rhabdomyomas susceptible to prenatal treatment with mTOR inhibitors: literature review and proposal of a prenatal management algorithm. Front Med (Lausanne). 2025, 12:1711774. 10.3389\/fmed.2025.1711774","journal-title":"Front Med (Lausanne)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/uog.70185","article-title":"Impact of prenatal sirolimus on cardiac rhabdomyomas and brain tubers","volume":"67","author":"Vergote S","year":"2026","unstructured":"Vergote S, Van der Veeken L, Chitayat D, Jaeggi E, Ryan G, Miller E, Shinar S. Impact of prenatal sirolimus on cardiac rhabdomyomas and brain tubers. Ultrasound Obstet Gynecol. 2026, 67:350-9. 10.1002\/uog.70185","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s44161-023-00280-4","article-title":"A case report of sirolimus use in early fetal management of lymphatic malformation","volume":"2","author":"Seront E","year":"2023","unstructured":"Seront E, Biard JM, Van Damme A, et al.. A case report of sirolimus use in early fetal management of lymphatic malformation. Nat Cardiovasc Res. 2023, 2:595-9. 10.1038\/s44161-023-00280-4","journal-title":"Nat Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-025-00708-3","article-title":"Effective sirolimus use in prenatal and postnatal management of symptomatic extensive congenital capillary-lymphatic-venous malformations (CLVMS): a report of two cases","volume":"27","author":"Klosowska A","year":"2025","unstructured":"Klosowska A, Styczewska M, Krawczyk MA, et al.. Effective sirolimus use in prenatal and postnatal management of symptomatic extensive congenital capillary-lymphatic-venous malformations (CLVMS): a report of two cases. Paediatr Drugs. 2025, 27:619-27. 10.1007\/s40272-025-00708-3","journal-title":"Paediatr Drugs"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/pd.6834","article-title":"In-utero therapy for fetal vascular anomalies: efficacy and tolerance of sirolimus administered to the pregnant patient","volume":"45","author":"Iacobas I","year":"2025","unstructured":"Iacobas I, Rosenberg TL, Sanz-Cortes M, Gowda SH, Nassr AA, Donepudi RV. In-utero therapy for fetal vascular anomalies: efficacy and tolerance of sirolimus administered to the pregnant patient. Prenat Diagn. 2025, 45:1039-44. 10.1002\/pd.6834","journal-title":"Prenat Diagn"},{"key":"ref23","unstructured":"Pfizer. Rapamune (sirolimus) prescribing information. (2025). Accessed: July 31, 2026: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=139."},{"key":"ref24","unstructured":"UK medicines in pregnancy. sirolimus. (2025). Accessed: July 31, 2026: https:\/\/www.medicinesinpregnancy.org\/leaflets-a-z\/sirolimus\/."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis NM","year":"2006","unstructured":"Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006, 82:1698-702. 10.1097\/01.tp.0000252683.74584.29","journal-title":"Transplantation"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.22551\/2021.31.0802.10180","article-title":"Maternal sirolimus therapy and fetal growth restriction","volume":"8","author":"Tshering S","year":"2021","unstructured":"Tshering S, Dorji N, Youden S, Wangchuk D. Maternal sirolimus therapy and fetal growth restriction. Arch Clin Cases. 2021, 8:19-24. 10.22551\/2021.31.0802.10180","journal-title":"Arch Clin Cases"},{"key":"ref27","article-title":"Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation","volume":"2006","author":"Armenti VT","year":"2006","unstructured":"Armenti VT, Daller JA, Constantinescu S, et al.. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Clin Transpl. 2006, 2006:57-70.","journal-title":"Clin Transpl"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/uog.13434","article-title":"Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus","volume":"45","author":"Mlczoch E","year":"2015","unstructured":"Mlczoch E, Hanslik A, Luckner D, Kitzm\u00fcller E, Prayer D, Michel-Behnke I. Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus. Ultrasound Obstet Gynecol. 2015, 45:618-21. 10.1002\/uog.13434","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-003-0590-4","article-title":"Fetal and neonatal cardiac tumors","volume":"25","author":"Isaacs H Jr","year":"2004","unstructured":"Isaacs H Jr. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004, 25:252-73. 10.1007\/s00246-003-0590-4","journal-title":"Pediatr Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1067\/s0022-3476(03)00494-3","article-title":"Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex","volume":"143","author":"Bader RS","year":"2003","unstructured":"Bader RS, Chitayat D, Kelly E, Ryan G, Smallhorn JF, Toi A, Hornberger LK. Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex. J Pediatr. 2003, 143:620-4. 10.1067\/s0022-3476(03)00494-3","journal-title":"J Pediatr"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)91109-j","article-title":"Natural history of cardiac rhabdomyoma in infancy and childhood","volume":"66","author":"Smythe JF","year":"1990","unstructured":"Smythe JF, Dyck JD, Smallhorn JF, Freedom RM. Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol. 1990, 66:1247-9. 10.1016\/0002-9149(90)91109-j","journal-title":"Am J Cardiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-0504","article-title":"Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex","volume":"118","author":"J\u00f3\u017awiak S","year":"2006","unstructured":"J\u00f3\u017awiak S, Kotulska K, Kasprzyk-Obara J, Doma\u0144ska-Pakie\u0142a D, Tomyn-Drabik M, Roberts P, Kwiatkowski D. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex. Pediatrics. 2006, 118:e1146-51. 10.1542\/peds.2006-0504","journal-title":"Pediatrics"},{"key":"ref33","unstructured":"International Society for the Study of Vascular Anomalies. ISSVA classification for vascular anomalies. (2025). Accessed: July 31, 2026: https:\/\/www.issva.org\/classification."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/JOVA.0000000000000113","article-title":"Updated classification of vascular anomalies: a living document from the International Society for the Study of Vascular Anomalies Classification Group","volume":"6","author":"Goldenberg DC","year":"2025","unstructured":"Goldenberg DC, Vikkula M, Penington A, Blei F, Kool LS, Wassef M, Frieden IJ. Updated classification of vascular anomalies: a living document from the International Society for the Study of Vascular Anomalies Classification Group. J Vasc Anom (Phila). 2025, 6:113. 10.1097\/JOVA.0000000000000113","journal-title":"J Vasc Anom (Phila)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042358","article-title":"ISSVA classification of vascular anomalies and molecular biology","volume":"23","author":"Kunimoto K","year":"2022","unstructured":"Kunimoto K, Yamamoto Y, Jinnin M. ISSVA classification of vascular anomalies and molecular biology. Int J Mol Sci. 2022, 23:2358. 10.3390\/ijms23042358","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies","volume":"136","author":"Wassef M","year":"2015","unstructured":"Wassef M, Blei F, Adams D, et al.. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015, 136:e203-14. 10.1542\/peds.2014-3673","journal-title":"Pediatrics"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1148\/rg.210234","article-title":"Vascular anomaly syndromes in the ISSVA classification system: imaging findings and role of interventional radiology in management","volume":"42","author":"Wang MX","year":"2022","unstructured":"Wang MX, Kamel S, Elsayes KM, et al.. Vascular anomaly syndromes in the ISSVA classification system: imaging findings and role of interventional radiology in management. Radiographics. 2022, 42:1598-620. 10.1148\/rg.210234","journal-title":"Radiographics"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-014-9453-2","article-title":"AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation","volume":"18","author":"Boscolo E","year":"2015","unstructured":"Boscolo E, Coma S, Luks VL, Greene AK, Klagsbrun M, Warman ML, Bischoff J. AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation. Angiogenesis. 2015, 18:151-62. 10.1007\/s10456-014-9453-2","journal-title":"Angiogenesis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"Luks VL","year":"2015","unstructured":"Luks VL, Kamitaki N, Vivero MP, et al.. Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr. 2015, 166:1048-54. 10.1016\/j.jpeds.2014.12.069","journal-title":"J Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1434493","article-title":"Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients","volume":"12","author":"Neirotti A","year":"2024","unstructured":"Neirotti A, Barat V, Coppo P, et al.. Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients. Front Pediatr. 2024, 12:1434493. 10.3389\/fped.2024.1434493","journal-title":"Front Pediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/523907-prenatal-use-of-sirolimus-in-fetal-therapy-current-evidence-clinical-applications-and-future-directions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:24:23Z","timestamp":1788809063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/523907-prenatal-use-of-sirolimus-in-fetal-therapy-current-evidence-clinical-applications-and-future-directions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":40,"URL":"https:\/\/doi.org\/10.7759\/cureus.115909","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}